Navigation auf uzh.ch

Suche

CRPP CYTIMM-Z

Publications

Selected publications of Onur Boyman of the past 10 years

Levin AM, Bates DL, Ring AM, Krieg C, Lin JT, Su L, Raeber ME, Bowman GR, Novick P, Pande VS, Kohrt HE, Fathman CG, Boyman O*, and Garcia KC*. Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'. Nature (2012) 484:529-533.

Bouchaud G, Gehrke S, Krieg C, Kolios A, Hafner J, Navarini AA, French LE, and Boyman O*. Epidermal IL-15Rα acts as endogenous antagonist of psoriasiform inflammation in mouse and man. Journal of Experimental Medicine (2013) 210:2105-2117.

Woytschak J, Keller N, Krieg C, Impellizzieri D, Thompson RW, Wynn TA, Zinkernagel AS, and Boyman O*. Type 2 interleukin-4 receptor signaling in neutrophils antagonizes their expansion and migration during infection and inflammation. Immunity (2016) 45:172-84.

Arenas-Ramirez N, Zou C, Popp S, Zingg D, Brannetti B, Wirth E, Calzascia T, Kovarik J, Sommer L, Zenke G, Woytschak J, Regnier CH, Katopodis A, and Boyman O*. Improved cancer immunotherapy by a CD25-mimobody conferring selectivity to human interleukin-2. Science Translational Medicine (2016) 8, 367ra166.

Spohn G, Arenas-Ramirez N, Bouchaud G, and Boyman O*. Endogenous polyclonal anti-IL-1 antibody responses potentiate IL-1 activity during pathogenic inflammation. Journal of Allergy and Clinical Immunology (2017) 139:1957-1965.

* = corresponding author

Full list of publications

 

Selected publications of Jana Pachlopnik of the past 10 years

Pachlopnik Schmid J, Côte M, Ménager MM, Burgess A, Nehme N, Ménasché G, Fischer A, de Saint Basile G. Inherited defects in lymphocyte cytotoxic activity. Immunological Reviews (2010) 235:10-23.

Pachlopnik Schmid J, Lemoine R, Nehme N, Cormier-Daire V, Revy P, Debeurme F, Debré M, Nitschke P, Bole-Feysot C, Legeai-Mallet L, Lim A, de Villartay JP, Picard C, Durandy A, Fischer A, de Saint Basile G. Polymerase epsilon1 mutation in a human syndrome with facial dysmorphism, immunodeficiency, livedo and short stature ("FILS syndrome"). Journal of Experimental Medicine (2012) 209:2323-30.

Vavassori S, Galson J, Trück J, van Den Berg A, Tamminga RYJ, Magerus-Chatinet A, Pellé O, Camenisch Gross U, Marques Maggio E, Prader S, Nüesch U, Mauracher A, Volkmer B, Speer O, Suda L, Röthlisberger B, Zimmermann DR, Müller R, Diepstra A, Visser L, Haralambieva E, Neven B, Rieux-Laucat F, Pachlopnik Schmid J*. Lymphadenopathy Driven by TCR-Vγ8Vδ1 T-Cell Expansion in FAS-Related Autoimmune Lymphoproliferative Syndrome. Blood Advances (2017) 1:1101-1106.

* = corresponding author

Full list of  publications

 

 

Weiterführende Informationen